Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
303M
-
Number of holders
-
265
-
Total 13F shares, excl. options
-
261M
-
Shares change
-
+9.55M
-
Total reported value, excl. options
-
$2.18B
-
Value change
-
+$63.9M
-
Put/Call ratio
-
0.88
-
Number of buys
-
128
-
Number of sells
-
-115
-
Price
-
$8.35
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q3 2023
323 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q3 2023.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 261M shares
of 303M outstanding shares and own 86.36% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (29.8M shares), VANGUARD GROUP INC (23.3M shares), BlackRock Inc. (22.7M shares), Madrone Advisors, LLC (16.4M shares), Nikko Asset Management Americas, Inc. (13.4M shares), Sumitomo Mitsui Trust Holdings, Inc. (13.4M shares), FARALLON CAPITAL MANAGEMENT LLC (10.2M shares), T. Rowe Price Investment Management, Inc. (7.42M shares), Bellevue Group AG (7.25M shares), and Jackson Square Partners, LLC (6.93M shares).
This table shows the top 265 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.